KM Research Hub
← 返回论文库
待处理 入排:排除 图源:待检查

Geographic Inequities in Access to Phase 3 Clinical Trials for Inflammatory Bowel Disease in the United States.

Taylor Boyd, Ashwin N Ananthakrishnan

Clin Gastroenterol Hepatol 22(3) 659-661.e3

PMID37572861
PMCIDPMC10858973
DOI10.1016/j.cgh.2023.07.026
发表日期2023-08-12
摘要

摘要

Randomized controlled trials (RCTs) are an important mode of access to treatments for patients with inflammatory bowel diseases (IBDs) (eg, Crohn's disease [CD], ulcerative colitis [UC]), and a critical step in the regulatory process toward the approval of new therapies. Prior studies examining disparities in RCT participation for patients with IBD have importantly focused on racial and age-related disparities.1,2 Lack of geographic access to trials may be an important barrier to participation and a source of inequity. The aim of our study was to geographically map access to phase 3 clinical trials in IBD within the United States, and identify the impact of rural residence and socioeconomic status on access to trials.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。